A 47-year-old man presented to his local hospital in Peru after a generalized tonic-clonic seizure. His family reported a history of prior stroke of unclear etiology. This case report discusses the approach to a first seizure (including in tropical regions like Peru), the relationship between stroke and seizures, the approach to stroke in the young, and how to diagnose rare diseases in resource-limited settings.
SchefferIEBerkovicSCapovillaG, et al.ILAE classification of the epilepsies: Position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):512-521. doi:10.1111/epi.13709.
2.
KrumholzAWiebeSGronsethGS, et al.Evidence-based guideline: Management of an unprovoked first seizure in adults. Neurology. 2015;84(16):1705-1713. doi:10.1212/WNL.0000000000001487.
MoyanoLMSaitoMMontanoSM, et al.Neurocysticercosis as a cause of epilepsy and seizures in two community-based studies in a cysticercosis-endemic region in Peru. In: FlisserA, ed. PLoS Negl Trop Dis. 2014;8(2):e2692. doi:10.1371/journal.pntd.0002692.
6.
RaibagkarPBerkowitzAL. The many faces of neurocysticercosis. J Neurol Sci. 2018;390:75-76. doi:10.1016/j.jns.2018.04.018.
7.
ThurmanDJBegleyCECarpioA, et al.The primary prevention of epilepsy: A report of the prevention task force of the international league against epilepsy. Epilepsia. 2018;59:905. doi:10.1111/epi.14068.
8.
AdamsHPBendixenBHKappelleLJ, et al.Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial harold. Stroke. 1993;23(1):35-41. doi:10.1161/01.STR.24.1.35.
9.
KimHJParkKDChoiKGLeeHW. Clinical predictors of seizure recurrence after the first post-ischemic stroke seizure. BMC Neurol. 2016;16(1):1-10. doi:10.1186/s12883-016-0729-6.
10.
StefanidouMDasRRBeiserAS, et al.Incidence of seizures following initial ischemic stroke in a community-based cohort: The framingham heart study. Seizure. 2017;47:105-110. doi:10.1016/j.seizure.2017.03.009.
11.
HaapaniemiEStrbianDRossiC, et al.The CAVE score for predicting late seizures after intracerebral hemorrhage. Stroke. 2014;45(7):1971-1976. doi:10.1161/STROKEAHA.114.004686.
12.
SerafiniAGigliGLGregoraciG, et al.Are early seizures predictive of epilepsy after a stroke? Results of a population-based study. Neuroepidemiology. 2015;45(1):50-58. doi:10.1159/000382078.
13.
FerlazzoEGaspariniSBeghiE, et al.Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors. Epilepsia. 2016;57(8):1205-1214. doi:10.1111/epi.13448.
14.
RedforsPHolmegaardLPedersenAJernCMalmgrenK. Long-term follow-up of post-stroke epilepsy after ischemic stroke: Room for improved epilepsy treatment. Seizure. 2020;76:50-55. doi:10.1016/j.seizure.2020.01.009.
15.
EkkerMSBootEMSinghalAB, et al.Epidemiology, aetiology, and management of ischaemic stroke in young adults. The Lancet Neurology. 2018;17(9):790-801. doi:10.1016/S1474-4422(18)30233-3.
16.
Kolominsky-RabasPLWeberMGefellerONeundoerferBHeuschmannPU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: Incidence, recurrence, and long-term survival in ischemic stroke subtypes: A population-based study. Stroke. 2001;32(12):2735-2740. doi:10.1161/hs1201.100209.
17.
PutaalaJMetsoAJMetsoTM, et al.Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke the Helsinki young stroke registry. Stroke. 2009;40(4):1195-1203. doi:10.1161/STROKEAHA.108.529883.
18.
WhittakerRDevineHGormanG, et al.Epilepsy in adults with mitochondrial disease: A cohort study. Anals of Neurol. 2015;78(6):949-957. doi:10.1002/ana.24525.
IizukaTSakaiF. Pathogenesis of stroke-like episodes in MELAS: Analysis of neurovascular cellular mechanisms. Curr Neurovasc Res. 2005;2(1):29-45. doi:10.2174/1567202052773544.
21.
BhatiaKDKrishnanPKortmanHKlostranecJKringsT. Acute cortical lesions in MELAS syndrome: Anatomic distribution, symmetry, and evolution. Am J Neuroradiol. 2020;41:167-173. doi:10.3174/ajnr.A6325.
22.
OyamaMIizukaTNakaharaJIzawaY. Neuroimaging pattern and pathophysiology of cerebellar stroke-like lesions in MELAS with m.3243A>G mutation: A case report. BMC Neurol. 2020;20:167. doi:10.1186/s12883-020-01748-7.
23.
KogaYPovalkoNNishiokaJKatayamaKKakimotoNMatsuishiT. MELAS and l-arginine therapy: Pathophysiology of stroke-like episodes. Ann N Y Acad Sci. 2010;1201:104-110. doi:10.1111/j.1749-6632.2010.05624.
24.
ParikhSGoldsteinAKaraaA, et al.Patient care standards for primary mitochondrial disease: A consensus statement from the mitochondrial medicine society. Genet Med. 2017;19(12):1380-1397. doi:10.1038/gim.2017.107.
25.
GanetzkyRDFalkMJ. 8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease. Mol Genet Metab. 2018;123:301-308. doi:10.1016/j.ymgme.2018.01.010.
26.
ParikhSGoldsteinAKaraaA, et al.Patient care standards for primary mitochondrial disease: A consensus statement from the mitochondrial medicine society. Genet Med. 2017;19(12):1-18. doi:10.1038/gim.2017.107.
27.
BarcelosIShadiackEGanetzkyRDFalkMJ. Mitochondrial medicine therapies: Rationale, evidence, and dosing guidelines. Curr Opin Pediatr. 2020;32(6):707-718. doi:10.1097/MOP.0000000000000954.
28.
StefanettiRJNgYSErringtonLBlainAPMcFarlandRGormanGS. l-Arginine in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. Neurology. 2022;98(23):e2318-e2328. doi:10.1212/WNL.0000000000200299.
29.
McLaneHCBerkowitzALPatenaudeBN, et al.Availability, accessibility, and affordability of neurodiagnostic tests in 37 countries. Neurology. 2015;85(18):1614-1622. doi:10.1212/WNL.0000000000002090.
30.
AbelC. Tomógrafos: Equipos insuficientes y defectuosos ante posible segunda ola. La República. November 19, 2020.
